Milbank is Once Again Named Indonesia International Firm of the Year 2020 by Chambers Asia Pacific

In recognition of its leading role on many of the most significant and high-profile finance transactions in Indonesia, Milbank was awarded Indonesia International Firm of the Year 2020 by Chambers Asia Pacific. Chambers Asia Pacific recognized Milbank for the fourth time in recent years for its market-leading work in Indonesia.

This award is attributed to successfully completing many of the most significant transactions in Indonesia in 2019, including the US$1.8 billion financing of the Jambaran-Tiung Biru (JTB) Gas Field, the project financing of the Riau CCGT power project in Sumatra, PT Lestari Banten Energi’s US$775 million project bond issuance, the sale of PT Indosat Tbk.’s US$450 million telecommunication tower portfolio, and PT Adaro Indonesia and PT Adaro Energy Tbk’s issuance of US$750 million senior notes. Additionally, six different Milbank partners were ranked and recognized for their work in Indonesia: David Zemans, Naomi Ishikawa, James Murray, Giles Kennedy, Jacqueline Chan and James Orme.

Mr. Zemans, Managing Partner of the firm's Singapore office and Milbank's Asia Practice, said: “Milbank has been active in Indonesia for more than 35 years and we are very honored to once again be recognized by Chambers Asia Pacific. Milbank is proud to be the go-to international law firm for ‘first of its kind’ and other innovative transactions in Indonesia.”

Milbank is a leading international law firm with a long history of successfully handling Indonesia’s largest and most complex transactions and servicing a diverse array of Indonesian clients in multiple sectors over a variety of practice areas, including M&A, banking and finance, capital markets, transportation finance, project finance and restructuring. In addition to the Chambers award, multiple transactions in Indonesia that Milbank advised on have received deal of the year recognition from a number of leading industry publications, including PFI, IJ Global and TXF.